22-29044780-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_001206998.2(ZNRF3):c.634C>A(p.Gln212Lys) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000148 in 1,610,972 control chromosomes in the GnomAD database, including 1 homozygotes. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000079 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00016 ( 1 hom. )
Consequence
ZNRF3
NM_001206998.2 missense, splice_region
NM_001206998.2 missense, splice_region
Scores
1
7
11
Splicing: ADA: 0.9566
1
1
Clinical Significance
Conservation
PhyloP100: 7.27
Genes affected
ZNRF3 (HGNC:18126): (zinc and ring finger 3) Enables frizzled binding activity and ubiquitin-protein transferase activity. Involved in cellular protein metabolic process and negative regulation of Wnt signaling pathway. Is integral component of plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High AC in GnomAd4 at 12 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNRF3 | NM_001206998.2 | c.634C>A | p.Gln212Lys | missense_variant, splice_region_variant | 5/9 | ENST00000544604.7 | NP_001193927.1 | |
ZNRF3 | NM_032173.4 | c.334C>A | p.Gln112Lys | missense_variant, splice_region_variant | 5/9 | NP_115549.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNRF3 | ENST00000544604.7 | c.634C>A | p.Gln212Lys | missense_variant, splice_region_variant | 5/9 | 1 | NM_001206998.2 | ENSP00000443824.2 | ||
ZNRF3 | ENST00000406323.3 | c.334C>A | p.Gln112Lys | missense_variant, splice_region_variant | 4/8 | 1 | ENSP00000384553.3 | |||
ZNRF3 | ENST00000402174.5 | c.334C>A | p.Gln112Lys | missense_variant, splice_region_variant | 5/9 | 2 | ENSP00000384456.1 |
Frequencies
GnomAD3 genomes AF: 0.0000788 AC: 12AN: 152190Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
12
AN:
152190
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000601 AC: 15AN: 249530Hom.: 0 AF XY: 0.0000443 AC XY: 6AN XY: 135386
GnomAD3 exomes
AF:
AC:
15
AN:
249530
Hom.:
AF XY:
AC XY:
6
AN XY:
135386
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000156 AC: 227AN: 1458782Hom.: 1 Cov.: 30 AF XY: 0.000135 AC XY: 98AN XY: 725928
GnomAD4 exome
AF:
AC:
227
AN:
1458782
Hom.:
Cov.:
30
AF XY:
AC XY:
98
AN XY:
725928
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152190Hom.: 0 Cov.: 30 AF XY: 0.0000807 AC XY: 6AN XY: 74338
GnomAD4 genome
AF:
AC:
12
AN:
152190
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
74338
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2023 | The c.634C>A (p.Q212K) alteration is located in exon 5 (coding exon 5) of the ZNRF3 gene. This alteration results from a C to A substitution at nucleotide position 634, causing the glutamine (Q) at amino acid position 212 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;T
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;D;D
Sift4G
Benign
T;T;T
Polyphen
P;.;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at